JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:1408-1414, doi:10.1016/j.jacc.2004.06.066
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, T.
Right arrow Articles by Node, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, T.
Right arrow Articles by Node, K.

Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation

Teruo Inoue, MD, FACC*,{dagger},*, Toshihiko Uchida, MD{dagger}, Masashi Sakuma, MD{dagger}, Yoshitaka Imoto{ddagger}, Yasushi Ozeki, PhD§, Yukio Ozaki, MD§, Yutaka Hikichi, MD* and Koichi Node, MD*

* Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
{dagger} Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Japan
{ddagger} Yufu Itonaga Company, Tokyo, Japan
§ Department of Laboratory Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Tamaho, Japan



View larger version (12K):

[in a new window]
 
Figure 1 Serial changes in P-selectin (CD62P) on the surface of platelets (left panel) and Mac-1 (CD11b) on the surface of neutrophils (right panel) after coronary stenting. Platelet P-selectin and neutrophil Mac-1 increased after coronary stenting in a time-dependent manner, and the maximum increase was at 48 h. Both changes were suppressed in the cilostazol group compared with the ticlopidine group. *p < 0.05 vs. baseline. **p < 0.01 vs. baseline. ***p < 0.001 vs. baseline. {dagger}p < 0.05 for intergroup comparison. {dagger}{dagger}p < 0.01 for intergroup comparison. Open circles = cilostazol group (n = 34); solid circles = ticlopidine group (n = 32). MFI = mean channel fluorescence intensity.

 


View larger version (21K):

[in a new window]
 
Figure 2 Correlation between angiographic late lumen loss and relative changes in platelet P-selectin (left panel) and neutrophil CD11b (right panel) at 48 h after coronary stenting. Open circles = cilostazol group (n = 34); solid circles = ticlopidine group (n = 32).

 


View larger version (36K):

[in a new window]
 
Figure 3 Cilostazol's direct action for Mac-1 (CD11b). Cilostazol inhibited an expression of Mac-1 on surface of neutrophils in vitro in a dose-dependent manner, compared with the control (+dimethyl sulfoxide [DMSO] +formyl-methyonyl leucyl phenylalanine [FMLP]). *p < 0.05. **p < 0.01.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.